chr2-44320279-CAG-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong
The NM_000341.4(SLC3A1):βc.1699_1700delβ(p.Arg567GlyfsTer9) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,614,056 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. R567R) has been classified as Likely benign.
Frequency
Consequence
NM_000341.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC3A1 | NM_000341.4 | c.1699_1700del | p.Arg567GlyfsTer9 | frameshift_variant | 10/10 | ENST00000260649.11 | |
PREPL | NM_001171613.2 | c.*1075_*1076del | 3_prime_UTR_variant | 14/14 | ENST00000409411.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC3A1 | ENST00000260649.11 | c.1699_1700del | p.Arg567GlyfsTer9 | frameshift_variant | 10/10 | 1 | NM_000341.4 | P1 | |
PREPL | ENST00000409411.6 | c.*1075_*1076del | 3_prime_UTR_variant | 14/14 | 1 | NM_001171613.2 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251212Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135750
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461730Hom.: 0 AF XY: 0.0000248 AC XY: 18AN XY: 727180
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74498
ClinVar
Submissions by phenotype
Cystinuria Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 17, 2022 | This sequence change creates a premature translational stop signal (p.Arg567Glyfs*9) in the SLC3A1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 119 amino acid(s) of the SLC3A1 protein. This variant is present in population databases (rs777575410, gnomAD 0.003%). This premature translational stop signal has been observed in individuals with cystinuria (PMID: 15635077, 28646536, 28717662). This variant is also known as p.R567fsX8. ClinVar contains an entry for this variant (Variation ID: 1071553). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 04, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at